D, W., SJ, W., & S, L. (2024). The impact of misclassification errors on the performance of biomarkers based on next-generation sequencing, a simulation study. Journal of biopharmaceutical statistics, 34(5), 700. https://doi.org/10.1080/10543406.2023.2269251
Chicago Style (17th ed.) CitationD, Wang, Wang SJ, and Lababidi S. "The Impact of Misclassification Errors on the Performance of Biomarkers Based on Next-generation Sequencing, a Simulation Study." Journal of Biopharmaceutical Statistics 34, no. 5 (2024): 700. https://doi.org/10.1080/10543406.2023.2269251.
MLA (9th ed.) CitationD, Wang, et al. "The Impact of Misclassification Errors on the Performance of Biomarkers Based on Next-generation Sequencing, a Simulation Study." Journal of Biopharmaceutical Statistics, vol. 34, no. 5, 2024, p. 700, https://doi.org/10.1080/10543406.2023.2269251.